glp 1 cardiovascular risk reduction Glucagon-like peptide receptor agonists: benefits and mechanisms of action glp 1 cardiovascular benefits GLP-1

van Es A et al

7 , e007301 (2018)

Easier said than done

Due to the low reporter ion intensities resulting from fragmentation of a low-abundant peptide and selecting only one fragment, the reporter ion intensities were summed across the chromatographic elution profile of the peptide

See recent WSJ article here Enthusiasts (biohackers?) and some longevity-focused clinicians believe that microdosing these drugs offers benefits beyond weight loss, such as improved metabolic health, glycemic control, reduced systemic inflammation, and potentially even a lower risk of age-related diseases

As we age, our natural levels of acetyl-carnitine decrease, leading to slower metabolism and reduced energy levels